- Current report filing (8-K)
January 16 2013 - 2:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 15,
2013
HUMAN
PHEROMONE SCIENCES, INC.
(Exact name of Registrant as specified in
its charter)
CALIFORNIA
|
0-23544
|
94-3107202
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
84 W.
SANTA CLARA STREET, SUITE 720, SAN JOSE, CALIFORNIA 95113
(Address of principal executive offices) (Zip code)
Registrant’s telephone number, including area code:
(408)
938-3030
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02(b).
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On January 15, 2013 Mr. Robert Marx informed
the Board of Directors of Human Pheromone Sciences, Inc. (the “Company”) of his resignation effective immediately for
personal reasons. Mr. Marx, who has served as an independent director of the Company since October 1994.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
HUMAN PHEROMONE SCIENCES, INC.
|
|
|
|
|
|
|
Date: January 16, 2013
|
By:
|
/s/ William P. Horgan
|
|
|
William P. Horgan, Chief Executive Officer
|
Human Pheromone Sciences (GM) (USOTC:EROX)
Historical Stock Chart
From May 2024 to Jun 2024
Human Pheromone Sciences (GM) (USOTC:EROX)
Historical Stock Chart
From Jun 2023 to Jun 2024